Clinics I work with
Selected research
-
Efficacy and safety of tildrakizumab 100 mg for plaque psoriasis in patients randomized to treatment continuation vs treatment withdrawal with retreatment upon relapse in reSURFACE 1.
Journal of the European Academy of Dermatology and Venereology : JEADV
-
Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8+ T cells in autoimmunity and cancer.
The Journal of allergy and clinical immunology
-
Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-a therapy.
JCI insight